Company profilePharmaceutical#750 of 1,318 in Pakistan✓ No DRAP alerts

PUNJAB MEDICAL SERVICES DSL: 05-352-0063-041061D

Pharmaceutical company · 11 brands · 18 molecules

Ranked #14 of 44 companies in Antineoplastics

11 registered products 13 pharmaceutical brands 18 distinct molecules 0 DRAP alerts

Company overview

11
registered products
13
pharmaceutical brands
18
distinct molecules
3
therapeutic classes
0
DRAP alerts

PUNJAB MEDICAL SERVICES DSL: 05-352-0063-041061D is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 11 product registrations across 18 distinct molecules. Its portfolio is concentrated in Antineoplastics and Antimycotics Systemic Use. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by PUNJAB

2 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

2
ceilings with an approval date
0
not revised in 2+ years
2026
oldest approval year
20262

Top molecules by brand count

Caspofungin2 brands
Abiraterone ...... 250 Mg1 brand
Docetaxel ...... 20 Mg1 brand
Docetaxel1 brand
Docetaxel ...... 80 Mg1 brand
Caspofungin ...... 70 Mg1 brand
Caspofungin ...... 50 Mg1 brand
5-Fluorouracil ...... 50 Mg1 brand
Letrozole ...... 2.5 Mg1 brand

Therapeutic classes

Antineoplastics · 5Antimycotics Systemic Use · 1Endocrine Hormone Therapy · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official14 products · Rs 353.82 – Rs 202,094.93
Median across source: Rs 11,105.51

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

A. J. MIRZA holds 14 molecules not in this portfolio
CaspofunginDacarbazineEtoposideEtoposide Usp 100MgGefitinibIrinotecan
Pharmasol (Pvt) Ltd. holds 116 molecules not in this portfolio
AcetazolamideAcyclovirAlpha KetoanaloguesAnastrazoleAnastrozoleAprepitant
Pfizer Laboratories (Pvt) Ltd. holds 132 molecules not in this portfolio
AlprazolamAluminium HydroxideAluminium Hydroxide And OxideAmlodipineAmodiaquineAmodiaquine Base

Get the full profile for PUNJAB

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.